Zebrafish streamline the way to understanding steatotic liver disease

Zebrafish streamline the way to understanding steatotic liver disease

Saved in:

Bibliographic Details
Main Authors:	Jessye C. Castro, Kimberley J. Evason
Format:	Article
Language:	English
Published:	The Company of Biologists 2024-11-01
Series:	Disease Models & Mechanisms
Online Access:	http://dmm.biologists.org/content/17/11/dmm052204
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Metabolic dysfunction-associated steatotic liver disease
by: Chieh Chen, et al.
Published: (2024-12-01)

Evaluation of Liver Fibrosis through Noninvasive Tests in Steatotic Liver Disease
by: Yuri Cho
Published: (2024-11-01)

Microbiota and metabolic dysfunction associated with steatotic liver disease
by: Q. Zhu, et al.
Published: (2024-09-01)

Treatment of HCV infection in patients with steatotic liver disease
by: Robert Flisiak, et al.
Published: (2024-07-01)

Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Myrsini Orfanidou, et al.
Published: (2024-12-01)

A new Korean nomenclature for steatotic liver disease
by: Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL)
Published: (2024-09-01)

Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Emidio Scarpellini, et al.
Published: (2024-11-01)

An overview of pathogenesis of metabolic dysfunction-associated steatotic liver disease
by: Shahid Habib, et al.
Published: (2024-11-01)

Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
by: Mengyao Yan, et al.
Published: (2024-10-01)

The plasma lipidome varies with the severity of metabolic dysfunction-associated steatotic liver disease
by: Clément J. F. Heymann, et al.
Published: (2024-12-01)

Non-invasive testing in metabolic dysfunction-associated steatotic liver disease
by: Sanad Dawod, et al.
Published: (2024-11-01)

Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Yiying Pei, et al.
Published: (2025-01-01)

Lymph Node Adiposity and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Jessica M. Rubino, et al.
Published: (2025-01-01)

Inhibiting Ferroptosis Prevents the Progression of Steatotic Liver Disease in Obese Mice
by: Gi Cheol Park, et al.
Published: (2024-10-01)

Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
by: K. L. Raikhelson, et al.
Published: (2024-05-01)

Mechanism of SIRT2 in Metabolic Dysfunction-associated Steatotic Liver Disease
by: DONG Kaixuan, et al.
Published: (2024-05-01)

Understanding the epidemiology of metabolic dysfunction-associated steatotic liver disease is essential for its management: need for attention to accurate diagnostic coding and classification
by: Han Ah Lee
Published: (2024-11-01)

Contribution of Sex Differences to Development of Cardiovascular Disease in Metabolic-Associated Steatotic Liver Disease (MASLD)
by: Lucy C. Taylor, et al.
Published: (2024-12-01)

Metabolic dysfunction-associated steatotic liver disease and risk of four intrahepatic and extrahepatic diseases
by: Yiyuan Xiao, et al.
Published: (2025-01-01)

Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
by: Gong Feng, et al.
Published: (2025-03-01)

Drug treatment for metabolic dysfunction-associated steatotic liver disease: Progress and direction
by: Da Zhou, et al.
Published: (2024-11-01)

Perirenal fat thickness is an independent predictor for metabolic syndrome in steatotic liver disease
by: Jong Wook Choi, et al.
Published: (2024-11-01)

Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review
by: Ludovico Abenavoli, et al.
Published: (2024-09-01)

Small intestinal bacterial overgrowth and metabolic dysfunction-associated steatotic liver disease
by: Ziteng Wang, et al.
Published: (2024-12-01)

Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake
by: Emil Deleuran Hansen, et al.
Published: (2025-01-01)

Liver macrophage activation: Relation with hepatic histopathological changes in patients with metabolic associated steatotic liver disease
by: Doaa H. Hegazy, et al.
Published: (2024-06-01)

Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease.
by: Martha R Smith, et al.
Published: (2024-01-01)

Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease
by: Martha R. Smith, et al.
Published: (2024-01-01)

O2- CHARACTERIZATION OF STEATOTIC LIVER DISEASE AND THE ROLE OF GENETIC BACKGROUND IN LATIN AMERICA
by: LUIS ANTONIO DÍAZ PIGA, et al.
Published: (2024-12-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease and Alcohol-Associated Liver Disease: Liver DNA Methylation Analysis—A Systematic Review
by: Daniela Stols-Gonçalves, et al.
Published: (2024-11-01)

Equivalent prevalence and progression of chronic kidney disease in non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
by: Hiroyuki Suzuki, et al.
Published: (2024-10-01)

P-118 METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: INDICATION FOR LIVER TRANSPLANTATION AND OCCURRENCE IN THE POSTOPERATIVE PERIOD
by: Felipe Ramos Caprini, et al.
Published: (2024-12-01)

Evidence summary of lifestyle interventions in adults with metabolic dysfunction-associated steatotic liver disease
by: Mei-jing Chen, et al.
Published: (2025-01-01)

Steatotic liver disease in people with HIV at Tshepong Hospital: A post-mortem analysis
by: Aqeela Moosa, et al.
Published: (2024-12-01)

Sex differences in metabolic dysfunction-associated steatotic liver disease: a narrative review
by: Sae Kyung Joo, et al.
Published: (2024-04-01)

The role of intestinal flora in metabolic dysfunction-associated steatotic liver disease and treatment strategies
by: Li Jun Wang, et al.
Published: (2025-01-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause and Cause-Specific Mortality
by: Rosa Oh, et al.
Published: (2025-01-01)

Nicotinamide Adenine Dinucleotide Phosphate Oxidases and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Vittoria Cammisotto, et al.
Published: (2025-01-01)

Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
by: Yu-Ming Cheng, et al.
Published: (2024-12-01)

Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”
by: Yixuan Zhu, et al.
Published: (2024-10-01)